Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PGHL
PGHL | NSE
4,809.40
INR10.60
0.22%
PGHL | NSE
Loading StockChartView...
About PGHL
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
01/04/2026
Close
4,809.40
Open
4,829.00
High
4,872.80
Low
4,799.90
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. It provides over-the-counter products vitamins minerals and supplements. The company offers its products under the Cosome Polybion Neurobion Evion Nasivion Livogen and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
View LessPGHL | NSE
Risk
20.0
Sharpe
-0.69
Luna's Score
52/100
Recommendation
Hold
Luna says (PGHL | NSE)
What's Working
Low 6-Month Volatility (<30%)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
21.7%1 month
20.0%3 months
22.8%6 months
19.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
42.84
Fwd. PE
-
Price to book
16.23
Debt to equity
0.02
Debt to assets
0.01
Ent. to EBITDA
28.13
Ent. to rev.
7.36
PEG
-
Other Fundamentals
EBITDA
3.07B
MarketCap
79.32B
MarketCap(USD)
852.60M
Div. yield
2.28
Op. margin
14.47
Erngs. growth
-42.90
Rev. growth
-5.70
Ret. on equity
31.18
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
221.30
Range1M
286.00
Range3M
1.19K
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.82
Price X volume
48.62M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.13 | 24.85 | Par |
| Ent. to Revenue | 7.36 | 11.40 | Cheaper |
| PE Ratio | 42.84 | 51.36 | Par |
| Price to Book | 16.23 | 6.83 | Expensive |
| Dividend Yield | 2.28 | 0.52 | Leader |
| Std. Deviation (3M) | 22.76 | 42.17 | Lower Risk |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 79.32B | 290.82B | Emerging |
